The incidence of Respiratory Distress Syndrome (RDS) decreases as the gestational age of the infant increases, with more severe cases occurring in smaller and more premature neonates. For instance, 98% of infants born at 24 weeks experience RDS, while the incidence drops to 5% at 34 weeks and to less than 1% by 37 weeks.
Understanding of the physiological challenges and the strategic application of anesthesia-related interventions is crucial. RDS results from a deficiency in pulmonary surfactant, leading to increased surface tension in the alveoli, which causes them to collapse and makes breathing laborious and inefficient.
From an anesthesia perspective, the primary focus is to support the respiratory function of these infants through the administration of exogenous surfactant. This intervention aims to reduce surface tension, thereby stabilizing the alveoli and improving respiratory mechanics. Surfactant therapy can have immediate effects on improving gas exchange and decreasing the work of breathing, critical factors in the stabilization of affected infants.
Additionally, the application of Continuous Positive Airway Pressure (CPAP) is widely utilized in the management of RDS. CPAP provides a constant positive pressure during the respiratory cycle, helping to keep the alveoli open and improve oxygenation. This method of respiratory support is especially beneficial in preventing further alveolar collapse and maintaining adequate lung volumes during the critical period of lung development.
Anesthesia providers must be adept at managing these interventions, often in a neonatal intensive care unit (NICU) setting. This includes monitoring for potential complications such as pneumothorax, which can arise from the use of CPAP, and ensuring the careful titration of respiratory and supportive therapies. Effective management of RDS requires a comprehensive understanding of neonatal respiratory physiology, skilled application of therapeutic interventions, and meticulous monitoring to adapt to the rapidly changing clinical status of these vulnerable patients.
| Condition | Ventilation approach | What it avoids |
|---|---|---|
| Congenital diaphragmatic hernia | Gentle ventilation with smaller tidal volumes and permissive hypercapnia | Aggressive hyperventilation, barotrauma and volutrauma to hypoplastic lungs |
| TEF and esophageal atresia | Maintain spontaneous ventilation as long as possible before the fistula is ligated | Positive pressure forcing air through the fistula into stomach and intestines |
| Congenital lobar emphysema | Support spontaneous ventilation; low tidal volumes and close monitoring of respiratory parameters | Further air trapping and worsening overinflation from positive pressure |
| Respiratory distress syndrome | Exogenous surfactant to reduce surface tension, with CPAP to hold alveoli open, monitoring for pneumothorax, which can arise from CPAP | Further alveolar collapse |
